A monoclonal antibody developed by GlaxoSmithKline and Vir Biotechnology successfully counteracts a new strain of SARS-CoV-2.
coronavirus disease 2019
Posted inClinical Trials, COVID-19, Infections
WHO: Convalescent Plasma Is Useless in Treating COVID-19
Convalescent plasma does not improve patient survival and does not reduce the need in mechanical ventilation.
Posted inCOVID-19, Infections, Regulatory
Molnupiravir: What U.S. Experts Said
FDA scientists took a detailed look at molnupiravir for treating COVID-19.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Lagevrio: New Antiviral Drug to Treat COVID-19
The oral antiviral drug molnupiravir by Merck & Co.
Posted inCOVID-19, Infections, Research
Famotidine for Treatment of COVID-19: Hope or Hype? The Most Comprehensive Review
Can a popular heartburn drug Pepcid help fight SARS-CoV-2?